Samir Ounzain is a molecular biologist with over 15 years of experience exploring the dark matter of the genome and its roles in development and disease. Prior to founding HAYA Therapeutics, Samir was a Project Leader and Research Fellow at the Lausanne University Hospital (CHUV), where his research efforts directly led to the discovery of hundreds of novel heart-enriched lncRNAs, most notably the lncRNAs CARMEN, Meteor and Wisper.
Speaking In
4:15 PM - 5:15 PM (PDT)
Wednesday, June 15
The power of RNA has become more evident during the COVID-19 pandemic. However, stakeholders…